1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEUROCRINE BIOSCIENCES, INC.
Neurocrine Biosciences, Inc. XNAS: NBIX
131.24 -3.89 (-2.88%)
629.3K
XNAS Volume

XNAS 15 Jul, 2025 5:30 PM (EDT)

Neurocrine Biosciences, Inc. - NBIX - stock price prediction, stock price target, analyst ratings from 26 analysts

Neurocrine Biosciences, Inc. has a share price target of US$ 162, revenue growth forecast of 14.1%, and profit growth estimate of 19.4% for FY25, based on top 26 analyst calls.